Gemcitabine and oxaliplatin in patients with unresectable biliary cancer including gall bladder cancer: a Korean Cancer Study Group phase II trial. - Wikidata - awgldk - TriplyDB

Gemcitabine and oxaliplatin in patients with unresectable biliary cancer including gall bladder cancer: a Korean Cancer Study Group phase II trial.

Gemcitabine and oxaliplatin in patients with unresectable biliary cancer including gall bladder cancer: a Korean Cancer Study Group phase II trial.

http://www.wikidata.org/entity/Q33385654

about

Targeted therapy in biliary tract cancers-current limitations and potentials in the future.Identification of active chemotherapy regimens in advanced biliary tract carcinoma: a review of chemotherapy trials in the past two decades A phase II trial of fixed-dose rate gemcitabine plus capecitabine in metastatic/advanced biliary tract cancer patients.Advanced biliary tract carcinomas: a retrospective multicenter analysis of first and second-line chemotherapy Phase II study of mFOLFOX3 (5-fluorouracil, leucovorin, oxaliplatin) as second-line treatment after gemcitabine failure in patients with unresectable/metastatic biliary tract cancer.Therapeutic options for intrahepatic cholangiocarcinoma Selective hypertrophy of the lobus caudatus as a novel approach enabling extended right hepatectomy in the presence of a non-perfused left lateral liver lobe Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysis.Cisplatin/gemcitabine or oxaliplatin/gemcitabine in the treatment of advanced biliary tract cancer: a systematic review.Transcatheter arterial chemoembolization with gemcitabine and oxaliplatin for the treatment of advanced biliary tract cancer.Comparison of the Efficacy between Gemcitabine-Cisplatin and Capecitabine-Cisplatin Combination Chemotherapy for Advanced Biliary Tract Cancer.Cholangiocarcinoma: Biology, Clinical Management, and Pharmacological Perspectives.Targeted therapy for biliary tract cancer.Current status of chemotherapy for the treatment of advanced biliary tract cancer.Emerging pharmacotherapeutic strategies for cholangiocarcinoma.Chemotherapy for the biliary tract cancers: moving toward improved survival time.Cholangiocellular Carcinoma.Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).Neoadjuvant chemotherapy in patients with locally advanced gallbladder cancer.Comparison of FOLFIRINOX Chemotherapy with Other Regimens in Patients with Biliary Tract Cancers: a Retrospective Study.Efficacy of a sequential treatment strategy with GEMOX-based followed by FOLFIRI-based chemotherapy in advanced biliary tract cancers.[Diagnostics and treatment of cholangiocellular carcinoma].Intra-arterial chemotherapy improved survival of stage 2-3 gallbladder cancer after curative resection.

P2860

Q30234532-7E7A0ECA-AF5D-4A08-81D5-1245C094D6A0 Q30300756-58CE2E48-D7B1-4F0D-8FA0-D117E716F3BF Q33399656-263F75EF-43D9-415F-A884-1E12D26106FE Q33417019-A38C2F0D-31F6-465F-B52F-0048FB069DE2 Q33420378-FC503729-D102-4FAD-BFE1-F71DE2EEFBB1 Q33621529-013373EF-6379-4067-B094-78E4E6D79663 Q34252744-EB42BC9D-2DA8-467E-A916-DD7ADD670724 Q34650742-2A1F828E-6516-4FF8-83AF-BE3DA3BD9182 Q34982545-5DD959CA-0688-4B05-B1F2-836A4A0C757B Q35179917-10E926B0-3FA4-4644-8D9C-18BDF845FAF9 Q35429914-1BF47359-67D4-44C0-A6F7-D53699360168 Q36962011-F43FFBA7-AAB0-44C2-ACCB-56DB55E71C07 Q37132750-48957980-62A4-4C64-A44A-84AC5412CD58 Q37138732-C6F5386F-5C38-4607-AD39-DF3E4C319FC5 Q37876403-6AB3CCBD-9B89-4B81-8D94-30D1876AEEE0 Q37983498-769F47AD-2150-438C-9A87-C870C709821B Q38746546-A6A0355A-4BE3-4764-8860-C1F52ABAB058 Q38812588-42EC8D92-AC10-4803-88A9-FA73D7EA0870 Q39008379-1A10C684-7D19-4D57-BE0D-F88689C87743 Q39313846-C3B1808E-0C93-4509-AE96-C682D344BCB2 Q39662945-07A9B75E-EFC2-416F-B48D-E1DE1D68EB75 Q51073522-2B1FBC82-390F-4AF7-B1AB-45E1A5FF4FEA Q55008534-AFA4AC44-D8BE-40C3-8913-10059C3A5B87

P2860

Gemcitabine and oxaliplatin in patients with unresectable biliary cancer including gall bladder cancer: a Korean Cancer Study Group phase II trial.

http://www.wikidata.org/entity/Q33385654

description

2009 nî lūn-bûn

@nan

2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Gemcitabine and oxaliplatin in ...... er Study Group phase II trial.

@ast

Gemcitabine and oxaliplatin in ...... er Study Group phase II trial.

@en

type

label

Gemcitabine and oxaliplatin in ...... er Study Group phase II trial.

@ast

Gemcitabine and oxaliplatin in ...... er Study Group phase II trial.

@en

prefLabel

Gemcitabine and oxaliplatin in ...... er Study Group phase II trial.

@ast

Gemcitabine and oxaliplatin in ...... er Study Group phase II trial.

@en

P1433

Q33385654-8B2FCB15-B78A-4606-9EBD-6DD7683D90C7

P1476

Q33385654-DE2EDDA1-2881-45EE-8DF2-3633219402D7

P2093

Q33385654-1F9783A3-53B2-4C73-B7FB-03DE06C43D5E

Q33385654-2E12CDCF-C325-461B-BA60-9300C86B3140

Q33385654-37ED0035-9D79-4A69-960C-BEC1EE598CBB

Q33385654-3DECD9BE-8D16-4CF4-8813-F6B3529EFFAA

Q33385654-5E889BA5-DCB5-4036-BCF5-075DB5A66B12

Q33385654-6EC5136B-A3EB-4340-922C-D3BBE172A495

Q33385654-7417A9CF-E3CF-49A0-86F2-EF85C67E9DBF

Q33385654-9CBB07EB-DC52-41D8-AC86-F31D17B5D5AE

Q33385654-9CD5872B-CDDA-4007-A962-77A9997CB790

Q33385654-9D2290F9-1B67-4B45-BE6E-64F78659AFE0

P2860

Q33385654-4579CC24-6C57-4C07-9EAE-3D21ADF75D1D

Q33385654-58AAFD49-6AEC-47F6-AEEB-0A95F3401BBF

P2888

Q33385654-D4C4B100-13FA-4297-97F6-0C0F3A827BC9

P304

Q33385654-4D4DEFBC-3E32-4716-8D74-D0A955CFF9F7

P31

Q33385654-EC18FD9A-05DA-44C7-9866-AE5FCCEB2519

P356

Q33385654-75FDF73A-66D7-471C-A64E-2EE887287EA3

P433

Q33385654-1E20A307-1DB7-4C3C-8C86-8B2FA14EB2A5

P478

Q33385654-DE2CD063-0249-4E11-BBAA-97D09BF01671

P577

Q33385654-72D50532-9299-49FC-A50D-DACD96C5CF31

P6179

Q33385654-D94459F7-4120-43D1-9BAB-990B883A776D

P698

Q33385654-31A248A7-04E4-4A0F-9190-F7A026A88844

P921

Q33385654-5B7BF567-DC32-4F34-AAF4-1026644FE759

P356

S00280-009-1069-7

P1433

Cancer Chemotherapy and Pharmacology

P1476

Gemcitabine and oxaliplatin in ...... er Study Group phase II trial.

@en

P2093

Bong Seog Kim

http://www.w3.org/2001/XMLSchema#string

Eunsik Park

http://www.w3.org/2001/XMLSchema#string

Ho Yeong Lim

http://www.w3.org/2001/XMLSchema#string

Hong Suk Song

http://www.w3.org/2001/XMLSchema#string

In Gyu Hwang

http://www.w3.org/2001/XMLSchema#string

Jae Ho Byun

http://www.w3.org/2001/XMLSchema#string

Joung-Soon Jang

http://www.w3.org/2001/XMLSchema#string

Kyung Hee Lee

http://www.w3.org/2001/XMLSchema#string

Myung Ah Lee

http://www.w3.org/2001/XMLSchema#string

NaeChoon Yoo

http://www.w3.org/2001/XMLSchema#string

P2860

Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer.

Review of gemcitabine in biliary tract carcinoma.

P2888

s00280-009-1069-7

P304

641-647

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00280-009-1069-7

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

65

http://www.w3.org/2001/XMLSchema#string

P577

2009-08-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1023953779

http://www.w3.org/2001/XMLSchema#string

P698

19652971

http://www.w3.org/2001/XMLSchema#string

P921

phase II clinical trial